Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.38 |
| ▸ | HPGDS | O60760 | 3/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5775331 | 0.98 | USP30 (0.37) | USP30HPGDSADORA3ADORA2BADORA1 | |
| SCHEMBL5772508 | 0.85 | HPGDS (0.34) | HPGDSCHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL5776799 | 0.84 | HPGDS (0.33) | HPGDSCHRNB2CHRNA4 | |
| SCHEMBL5776818 | 0.83 | USP30 (0.35) | USP30HPGDSCHRNB2CHRNA4CHRNA3 | |
| Hydrochloric Acid SCHEMBL5773710 | 0.81 | USP30 (0.34) | USP30 | |
| Hydrochloric Acid SCHEMBL5777261 | 0.77 | HPGDS (0.39) | HPGDSCHRNB2CHRNA4 | |
| SCHEMBL15580371 | 0.69 | SLC18A3 (0.55) | CHRNB2CHRNA4 | |
| SCHEMBL4237630 | 0.69 | SLC18A3 (0.55) | CHRNB2CHRNA4 | |
| SCHEMBL5776561 | 0.69 | MEN1 (0.31) | — | |
| SCHEMBL5772664 | 0.68 | MEN1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| US-6583154-B1 | Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines | AMGEN INC. | 2003-06-24 | — | — | US | disclosed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | disclosed |